Nektar Therapeutics
NKTR
#4891
Rank
HK$14.88 B
Marketcap
HK$440.62
Share price
-0.69%
Change (1 day)
538.74%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$79.57

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$79.93. In 2024 the company made an earnings per share (EPS) of -HK$69.43 an increase over its 2023 EPS that were of -HK$171.61.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$79.5714.6%
2024-HK$69.43-59.54%
2023-HK$171.61-25.89%
2022-HK$231.55-31.12%
2021-HK$336.1614.86%
2020-HK$292.67-1.19%
2019-HK$296.20-163.96%
2018HK$463.11-725.4%
2017-HK$74.05-42.73%
2016-HK$129.2983.33%
2015-HK$70.5239.53%
2014-HK$50.54-69.29%
2013-HK$164.56-6.67%
2012-HK$176.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.46-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.27-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.47-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$16.69-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.88-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.46-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$7.29-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland